Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Juan Diego Vera |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Electrophysiological and clinical predictors of methylphenidate, guanfacine, and combined treatment outcomes in children with attention deficit hyperactivity disorder / Giorgia Michelini en Journal of the American Academy of Child & Adolescent Psychiatry, Año 2023 - Vol. 62 - No. 4 (Abril)
[artículo]
Título : Electrophysiological and clinical predictors of methylphenidate, guanfacine, and combined treatment outcomes in children with attention deficit hyperactivity disorder Tipo de documento: texto impreso Autores: Giorgia Michelini, Autor ; Agatha Lenartowicz, Autor ; Juan Diego Vera, Autor Fecha de publicación: 2023 Artículo en la página: pp. 415-426 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno por déficit de atención e hiperactividad, Metilfenidato, Guanfacina, Electroencefalografía, Vaticinador Resumen: The combination of d-methylphenidate and guanfacine (an α-2A agonist) has emerged as a potential alternative to either monotherapy in children with attention-deficit/hyperactivity disorder (ADHD), but it is unclear what predicts response to these treatments. Link: ./index.php?lvl=notice_display&id=29834
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2023 - Vol. 62 - No. 4 (Abril) . - pp. 415-426[artículo] Electrophysiological and clinical predictors of methylphenidate, guanfacine, and combined treatment outcomes in children with attention deficit hyperactivity disorder [texto impreso] / Giorgia Michelini, Autor ; Agatha Lenartowicz, Autor ; Juan Diego Vera, Autor . - 2023 . - pp. 415-426.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2023 - Vol. 62 - No. 4 (Abril) . - pp. 415-426
Palabras clave: Trastorno por déficit de atención e hiperactividad, Metilfenidato, Guanfacina, Electroencefalografía, Vaticinador Resumen: The combination of d-methylphenidate and guanfacine (an α-2A agonist) has emerged as a potential alternative to either monotherapy in children with attention-deficit/hyperactivity disorder (ADHD), but it is unclear what predicts response to these treatments. Link: ./index.php?lvl=notice_display&id=29834